CellTrans Inc. is a pioneering cell therapy company based in Chicago, IL, dedicated to advancing cell therapies for clinical application. Led by Dr. Jos Oberholzer, a renowned expert in transplantation surgery, the company offers world-class services for autologous and allogeneic islet isolations, pre-clinical testing, and in vitro cell product assessments. With a mission to improve the human condition through bioengineered cell transplantation, CellTrans is at the forefront of developing functional cures for various diseases.
Under the leadership of Dr. James McGarrigle, the Chief Operating Officer, CellTrans ensures the highest standards of functionality and quality in the manufacture of human islet cells within a cGMP-compliant facility. Driven by a commitment to continuous process improvement, the company develops scalable manufacturing processes that meet regulatory requirements. Dr. Giovanna La Monica, the Director of Quality, oversees the production of isolated pancreatic islets for transplantation, ensuring consistent quality through good manufacturing practices. With a team of experts and a focus on removing barriers to transplantation, CellTrans is dedicated to improving access to life-changing cell therapies.
Generated from the website